Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neumora Therapeutics, Inc. | Chief Financial Officer | Common Stock | 139K | $1.58M | $11.39 | Aug 27, 2024 | Indirect |
Neumora Therapeutics, Inc. | Chief Financial Officer | Common Stock | 85K | $968K | $11.39 | Aug 27, 2024 | Direct |
Neumora Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 170K | Feb 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NMRA | Neumora Therapeutics, Inc. | Aug 27, 2024 | 1 | -$179K | 4 | Aug 27, 2024 | Chief Financial Officer |
NMRA | Neumora Therapeutics, Inc. | Aug 22, 2024 | 3 | -$984K | 4 | Aug 26, 2024 | Chief Financial Officer |
NMRA | Neumora Therapeutics, Inc. | Apr 17, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Chief Financial Officer |
NMRA | Neumora Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 16, 2024 | Chief Financial Officer |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Chief Financial Officer |